Expression of Mig (Monokine Induced by Interferon-γ) Is Important in T Lymphocyte Recruitment and Host Defense Following Viral Infection of the Central Nervous System1

Induction of a Th1 immune response against viral infection of the CNS is important in contributing to viral clearance. The present studies demonstrate a role for the T cell chemoattractant chemokine Mig (monokine induced by IFN-γ) in contributing to a Th1 response against mouse hepatitis virus infection of the CNS. Analysis of the kinetics of Mig expression revealed mRNA transcripts present at days 7 and 12 postinfection (p.i.) but not early (day 2) or late (day 35) in the infection. To determine functional significance, mouse hepatitis virus-infected mice were treated with anti-Mig antisera, and the severity of disease was evaluated. Such treatment resulted in a marked increase in mortality that correlated with a >3 log increase in viral burden within the brains as compared with control mice treated with normal rabbit serum. Anti-Mig-treated mice displayed a significant decrease (p < 0.005) in CD4+ and CD8+ T cell recruitment into the CNS as compared with normal rabbit serum-treated mice. In addition, anti-Mig treatment resulted in a significant decrease (p < 0.05) in levels of IFN-γ and IFN-β that coincided with increased (p < 0.02) expression of the anti-inflammatory Th2 cytokine IL-10 within the CNS. Collectively, these data indicate that Mig is important in contributing to host defense by promoting a protective Th1 response against viral infection of the CNS.

[1]  M. Buchmeier,et al.  Cutting Edge: The T Cell Chemoattractant IFN-Inducible Protein 10 Is Essential in Host Defense Against Viral-Induced Neurologic Disease1 , 2000, The Journal of Immunology.

[2]  C. Biron,et al.  A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. , 2000, The Journal of clinical investigation.

[3]  J. Newcombe,et al.  Expression of the interferon‐γ‐inducible chemokines IP‐10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions , 2000, Neuropathology and applied neurobiology.

[4]  M. Buchmeier,et al.  A Central Role for CD4+ T Cells and RANTES in Virus-Induced Central Nervous System Inflammation and Demyelination , 2000, Journal of Virology.

[5]  D. Adams,et al.  Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. , 1999, Journal of immunology.

[6]  M. Salvadori,et al.  Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. , 1999, Journal of the American Society of Nephrology : JASN.

[7]  M. Burdick,et al.  IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. , 1999, Journal of immunology.

[8]  A. Focà,et al.  Altered cytokine production after human herpes virus type 6 infection. , 1999, The new microbiologica.

[9]  R. Yezierski,et al.  Neuroprotective Effects of Interleukin-10 Following Excitotoxic Spinal Cord Injury , 1999, Experimental Neurology.

[10]  M. Buchmeier,et al.  Viral-induced neurodegenerative disease , 1999, Current Opinion in Microbiology.

[11]  Jakob S. Jensen,et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.

[12]  N. Sarvetnick,et al.  Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. , 1999, Journal of immunology.

[13]  G. Karupiah,et al.  The Interferon-Inducible Chemokines MuMig and Crg-2 Exhibit Antiviral Activity In Vivo , 1999, Journal of Virology.

[14]  D. Hinton,et al.  IFN-γ Is Required for Viral Clearance from Central Nervous System Oligodendroglia , 1999, The Journal of Immunology.

[15]  M. Roncarolo,et al.  A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.

[16]  R. Strieter,et al.  Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1α and monocyte chemotactic protein-1 , 1998, Journal of Neuroimmunology.

[17]  E. Bröcker,et al.  Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. , 1998, The American journal of pathology.

[18]  Y. Chen,et al.  Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. , 1998, Cellular immunology.

[19]  A. Faden,et al.  Interleukin-10 Improves Outcome and Alters Proinflammatory Cytokine Expression after Experimental Traumatic Brain Injury , 1998, Experimental Neurology.

[20]  J. Finke,et al.  The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. , 1998, Journal of immunology.

[21]  C. Mackay,et al.  The chemokine receptor CXCR3 mediates rapid and shear‐resistant adhesion‐induction of effector T lymphocytes by the chemokines IP10 and Mig , 1998, European journal of immunology.

[22]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[23]  M. Buchmeier,et al.  Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. , 1998, Journal of immunology.

[24]  D. Taub,et al.  CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10. , 1998, Journal of immunology.

[25]  L. Steinman,et al.  Perivascular T Cells Express the Pro‐Inflammatory Chemokine RANTES mRNA in Multiple Sclerosis Lesions , 1997, Scandinavian journal of immunology.

[26]  J. Teruya-Feldstein,et al.  Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo , 1997 .

[27]  J. Farber Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.

[28]  M. Buchmeier,et al.  Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus , 1997, Journal of virology.

[29]  R. Ransohoff,et al.  Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. , 1997, The American journal of pathology.

[30]  Simon A. Jones,et al.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes , 1996, The Journal of experimental medicine.

[31]  T. Olsson,et al.  Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β , 1996, Journal of Neuroimmunology.

[32]  R. Strieter,et al.  An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. , 1995, Journal of immunology.

[33]  R. Donnelly,et al.  Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes. , 1995, Journal of immunology.

[34]  P. Vanguri Interferon-γ-inducible genes in primary glial cells of the central nervous system: comparisons of astrocytes with microglia and Lewis with Brown Norway rats , 1995, Journal of Neuroimmunology.

[35]  M. Buchmeier,et al.  Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo , 1994, Journal of virology.

[36]  J. Farber HuMig: a new human member of the chemokine family of cytokines. , 1993, Biochemical and biophysical research communications.

[37]  F. Bloom,et al.  The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system , 1992, Virology.

[38]  J. Farber,et al.  Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. , 1990, The Journal of biological chemistry.

[39]  S. Stohlman,et al.  Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells , 1990, Journal of virology.

[40]  J. Farber A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  S. Mohri,et al.  Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection. , 1987, Antiviral research.

[42]  M. Buchmeier,et al.  Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence , 1986, Journal of virology.

[43]  Andrew D. Luster,et al.  γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.

[44]  K. Fujiwara,et al.  Utility of mouse cell line DBT for propagation and assay of mouse hepatitis virus. , 1978, The Japanese journal of experimental medicine.

[45]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[46]  J. Fleming,et al.  Pathogenesis of mouse hepatitis virus-induced demyelination. , 1996, Journal of neurovirology.